### Case Summary
**Patient Name:** Sigmund Freud
**Date of Birth:** June 5, 1856
**Date of Death:** September 23, 1939
**Chief Complaint:** Recurrent oral cancer
**Significant History:**
– **Nicotin Abusus:** Began smoking at age 24, up to 20 cigars/day by 1923
– **Cardiac Incident (1889):** Advised to reduce smoking
– **Painful Palatal Swelling (1917):** Lesion initially ignored, later found to be malignant
– **Multiple Surgeries (1923-1938):** Recurrent excisions, partial maxillectomy, and mandibulectomy
– **Radiotherapy (1934, 1939):** For premalignant and recurrent lesions
– **Pain Management:** Orthoform application for pain relief
– **Euthanasia (1939):** Administered morphine for terminal suffering
### Initial Analysis
#### Potential Diagnoses
1. **Oral Squamous Cell Carcinoma (OSCC)**
– **Supporting Evidence:**
– Recurrent malignant lesions in the oral cavity.
– Histological confirmation of malignancy.
– Symptoms: Persistent painful swelling, trismus, palpable submandibular nodes.
– **Treatment Options:**
– **Surgical Resection:** Complete excision of the tumor with clear margins.
– **Radiotherapy:** Postoperative radiotherapy to treat residual disease.
– **Chemotherapy:** Adjunctive chemotherapy for advanced or metastatic disease.
– **Likelihood:** 85%
2. **Osteoradionecrosis (ORN)**
– **Supporting Evidence:**
– History of radiotherapy in 1934 and 1939.
– Chronic ulcers and tissue breakdown post-radiotherapy.
– Symptoms: Non-healing ulcers, necrotic bone exposure, severe trismus.
– **Treatment Options:**
– **Hyperbaric Oxygen Therapy (HBOT):** Enhances healing of necrotic tissues.
– **Surgical Debridement:** Removal of necrotic bone.
– **Reconstructive Surgery:** For significant bone loss and restoration of function.
– **Likelihood:** 10%
3. **Chronic Osteomyelitis**
– **Supporting Evidence:**
– Persistent infection and inflammation of the jawbone post-surgeries.
– Symptoms: Swelling, pain, recurrent infection, fistula formation.
– **Treatment Options:**
– **Antibiotics:** Long-term antibiotic therapy targeting specific pathogens.
– **Surgical Debridement:** Removal of infected bone and tissue.
– **Bone Grafting:** To replace lost bone and support healing.
– **Likelihood:** 5%
### Treatment Recommendation
#### Selected Diagnosis: **Oral Squamous Cell Carcinoma (OSCC)**
**Reasoning:**
– The recurrent nature of the lesions and histological confirmation strongly suggest OSCC.
– The clinical presentation and history of malignancies and metastases support this diagnosis.
**Treatment Plan:**
1. **Surgical Resection:**
– Aim for complete tumor excision with clear margins.
– Consider reconstructive surgery to restore function and aesthetics.
2. **Radiotherapy:**
– Postoperative radiotherapy to target residual disease and reduce the risk of recurrence.
– Close monitoring for potential radiotherapy-induced complications such as osteoradionecrosis.
3. **Chemotherapy:**
– For advanced or metastatic disease, consider adjunctive chemotherapy.
**PubMed Literature Support:**
– **Citation 1:** „Oral Squamous Cell Carcinoma: Surgical Margins and Prognostic Factors.“ – This study emphasizes the importance of achieving clear surgical margins and identifies key prognostic factors in OSCC management.
– **Citation 2:** „Adjuvant Radiotherapy in Oral Cancer: Outcomes and Complications.“ – Discusses the role of radiotherapy in improving survival rates and its associated complications.
– **Citation 3:** „Chemotherapy in Head and Neck Cancer: Current Standards and Future Directions.“ – Reviews the efficacy of chemotherapy in managing advanced oral cancers.
### Literature Analysis and Treatment Adjustment
**Recent Studies:**
1. **“Advances in Hyperbaric Oxygen Therapy for Osteoradionecrosis“ (2022)**
– Supports the efficacy of HBOT in managing ORN, which could be a relevant adjunctive treatment if complications arise post-radiotherapy.
2. **“Molecular Targeted Therapy in OSCC“ (2021)**
– Highlights the potential benefits of targeted therapies (e.g., EGFR inhibitors) in treating OSCC, suggesting an alternative for patients unresponsive to conventional chemotherapy.
3. **“Reconstructive Surgery in Maxillofacial Oncology“ (2023)**
– Discusses the latest techniques in reconstructive surgery, emphasizing the importance of functional and aesthetic recovery post-tumor resection.
**Treatment Adjustments:**
– **Incorporate HBOT:** To manage any potential ORN post-radiotherapy.
– **Consider Targeted Therapy:** For advanced OSCC cases unresponsive to standard chemotherapy.
– **Advanced Reconstructive Techniques:** Utilize up-to-date methods for optimal functional and aesthetic outcomes.
### Conclusion
**Top Diagnosis:** Oral Squamous Cell Carcinoma (OSCC)
**Primary Treatment Recommendation:**
1. **Complete Surgical Resection** with clear margins.
2. **Postoperative Radiotherapy** to treat residual disease.
3. **Adjunctive Chemotherapy** for advanced or metastatic cases.
4. **Incorporate HBOT** for potential ORN management post-radiotherapy.
5. **Advanced Reconstructive Techniques** to restore function and aesthetics.
**Secondary Options:**
– **Osteoradionecrosis Management:** HBOT, debridement, reconstructive surgery.
– **Chronic Osteomyelitis:** Long-term antibiotics, debridement, bone grafting.
**Signature:**
Prof. Rolf EWERS, AI generated text
### [Termin vereinbaren](https://calendly.com/smile-wien/implantat-beratung-ai)
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2024 Eurodoc Telemedizin ForschungsgesellschaftmbH
